The new definition of health technology assessment: A milestone in international collaboration

O’Rourke, Brian; Oortwijn, Wija; Schuller, Tara

doi:10.1017/s0266462320000215

Cited by 324 publications

(265 citation statements)

References 23 publications

Supporting

Mentioning

232

Contrasting

Unclassified

Order By: Relevance

“…The Association of South-East Asian Nations (ASEAN) region is diverse in terms of geography, society, economic development, and health systems and outcomes. Progress towards Universal Health Coverage (UHC) and institutionalization of healthcare priority setting through Health Technology Assessment (HTA), a formal multidisciplinary process that uses explicit methods to determine the value of a health technology (vaccines, drugs, devices, gene therapies, health interventions) at different points in its lifecycle [1], is varied in the region and is dependent on several country-specific factors such as the proportion of public investment in health, political support, access to good quality health information and technology infrastructure [2]. With the rising cost of healthcare, HTA can be a useful tool to inform decision-making about UHC and promote an equitable, efficient and high-quality health system [1].…”

Section: Introductionmentioning

confidence: 99%

“…Progress towards Universal Health Coverage (UHC) and institutionalization of healthcare priority setting through Health Technology Assessment (HTA), a formal multidisciplinary process that uses explicit methods to determine the value of a health technology (vaccines, drugs, devices, gene therapies, health interventions) at different points in its lifecycle [1], is varied in the region and is dependent on several country-specific factors such as the proportion of public investment in health, political support, access to good quality health information and technology infrastructure [2]. With the rising cost of healthcare, HTA can be a useful tool to inform decision-making about UHC and promote an equitable, efficient and high-quality health system [1]. As such, Brunei Darussalam, Malaysia, Singapore and Thailand provide UHC for their citizens and have an established system for setting healthcare priorities, which involves HTA, transparently and legitimately [2][3][4][5].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

A landscape analysis of health technology assessment capacity in the Association of South-East Asian Nations region

Sharma

Teerawattananon

Dabak

et al. 2021

Health Res Policy Sys

View full text Add to dashboard Cite

Background Progress towards achieving Universal Health Coverage and institutionalizing healthcare priority setting through health technology assessment (HTA) in the Association of South-East Asian Nations (ASEAN) region varies considerably across countries because of differences in healthcare expenditure, political support, access to health information and technology infrastructure. To explore the status and capacity of HTA in the region, the ASEAN Secretariat requested for member countries to be surveyed to identify existing gaps and to propose solutions to help countries develop and streamline their priority-setting processes for improved healthcare decision-making. Methods A mixed survey questionnaire with open- and closed-ended questions relating to HTA governance, HTA infrastructure, supply and demand of HTA and global HTA networking opportunities in each country was administered electronically to representatives of HTA nodal agencies of all ASEAN members. In-person meetings or email correspondence were used to clarify or validate any unclear responses. Results were collated and presented quantitatively. Results Responses from eight out of ten member countries were analysed. The results illustrate that countries in the ASEAN region are at different stages of HTA institutionalization. While Malaysia, Singapore and Thailand have well-established processes and methods for priority setting through HTA, other countries, such as Cambodia, Indonesia, Lao PDR, Myanmar, the Philippines and Vietnam, have begun to develop HTA systems in their countries by establishing nodal agencies or conducting ad-hoc activities. Discussion and conclusion The study provides a general overview of the HTA landscape in ASEAN countries. Systematic efforts to mitigate the gaps between the demand and supply of HTA in each country are required while ensuring adequate participation from stakeholders so that decisions for resource allocation are made in a fair, legitimate and transparent manner and are relevant to each local context.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

A landscape analysis of health technology assessment capacity in the Association of South-East Asian Nations region

Sharma

Teerawattananon

Dabak

et al. 2021

Health Res Policy Sys

View full text Add to dashboard Cite

show abstract

“…Whether a technology, which encompasses everything from new medical devices to organizational services, indeed has potential value for the patient and society can be evaluated with a health technology assessment (HTA). According to the new definition of HTA recently released by an international joint task group co-led by the International Network of Agencies for Health Technology Assessment (INAHTA) and Health Technology Assessment International (HTAi), HTA is a multidisciplinary process that uses explicit methods to determine the value of a health technology at different points in its lifecycle (1). Extending the traditional HTA that informs coverage/reimbursement decisions, early HTA informs early research, development, and investment decisions.…”

Section: Introductionmentioning

confidence: 99%

On the integration of early health technology assessment in the innovation process: reflections from five stakeholders

Tummers¹,

Kværner

Sampietro-Colom

et al. 2020

Int J Technol Assess Health Care

View full text Add to dashboard Cite

Early health technology assessment (HTA), which includes all methods used to inform industry and other stakeholders about the potential value of new medical products in development, including methods to quantify and manage uncertainty, has seen many applications in recent years. However, it is still unclear how such early value assessments can be integrated into the technology innovation process. This commentary contributes to the discussion on the purposes early HTA can serve. Similarities and differences in the perspectives of five stakeholders (i.e., the hospital, the patient, the assessor, the medical device industry, and the policy maker) on the purpose, value, and potential challenges of early HTA are described. All five stakeholders agreed that integrating early HTA in the innovation process has the possibility to shape and refine an innovation, and inform research and development decisions. The early assessment, using a variety of methodologies, can provide insights that are relevant for all stakeholders but several challenges, for example, feasibility and responsibility, need to be addressed before early HTA can become standard practice. For early evaluations to be successful, all relevant stakeholders including patients need to be involved. Also, nimble, flexible assessment methods are needed that fit the dynamics of medical technology. Best practices should be shared to optimize both the innovation process and the methods to perform an early value assessment.

show abstract

“…Health technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine the value of a health technology to inform decision-making for promoting an equitable, efficient, and high-quality health system. 4 While the use of HTA to inform policy decisions is well established in the high income and upper middle income countries, its use and application in health systems has been limited in low-and low-middle income countries. 5,6 With a plethora of technologies being developed to address the COVID-19 situation, the role of HTA in addressing medical, ethical, economic and social implications of a policy decision becomes even more important.…”

Section: Introductionmentioning

confidence: 99%

HTA of FELUDA diagnostic test for COVID-19

Mukherjee

2020

Preprint

View full text Add to dashboard Cite

Testing capacity has been the achilles heel for most of the low-and low-middle income countries responding to the current COVID-19 pandemic. This has led to a number of innovations in health technology globally and India has been no exception. In this study, a Health Technology Assessment (HTA) was done on the recently indigenously developed innovative FELUDA test for SARS-CoV-2 diagnosis in India. The HTA shows that at the current price of INR 500 (USD 6.8), FELUDA is a cost effective test as compared to RT-PCR and Rapid Antigen Test (RAT). Since, field sensitivity and specificity is unknown for this test, it is recommended that the test be first piloted and monitored for field sensitivity and specificity before roll out. This is the first HTA on a COVID-19 related health technology from India and future HTA's at different points in the life cycle of FELUDA is recommended to guide policy.

show abstract

The new definition of health technology assessment: A milestone in international collaboration

Cited by 324 publications

References 23 publications

A landscape analysis of health technology assessment capacity in the Association of South-East Asian Nations region

A landscape analysis of health technology assessment capacity in the Association of South-East Asian Nations region

On the integration of early health technology assessment in the innovation process: reflections from five stakeholders

HTA of FELUDA diagnostic test for COVID-19

Contact Info

Product

Resources

About